83853-101-01 : NDC 2026 Code

83853-101-01 : Levacetylleucine ( Aqneursa )

Additionally :

You can get information about “83853-101-01” NDC code in 83853-101-01 in HTML format

HTML | 83853-101-01 in TXT (Plain Text) format

TXT | 83853-101-01 in PDF (Portable Document Format)

PDF | 83853-101-01 in XML format

XML formats.

NDC Code : 83853-101-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "83853-101-01",
    "PackageDescription": "28 PACKET in 1 CARTON (83853-101-01)  / 1 GRANULE, FOR SUSPENSION in 1 PACKET",
    "NDC11Code": "83853-0101-01",
    "ProductNDC": "83853-101",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Aqneursa",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Levacetylleucine",
    "DosageFormName": "GRANULE, FOR SUSPENSION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20240924",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA219132",
    "LabelerName": "IntraBio Inc",
    "SubstanceName": "LEVACETYLLEUCINE",
    "StrengthNumber": "1000",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Bile Salt Export Pump Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-01-28",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20240924",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}